编辑评论：软组织内骨的奇异事件：髋关节镜检查后异位骨化是有趣的发现还是并发症？
Editorial Commentary: The Curious Incident of the Bone in the Soft Tissue: Is Heterotopic Ossification After Hip Arthroscopy an Interesting Finding or Is It a Complication?
机构信息
Arlington, Virginia.
University of Maryland.
出版信息
Arthroscopy. 2020 Feb;36(2):462-463. doi: 10.1016/j.arthro.2019.10.007.
PMID:32014177
Abstract
Heterotopic ossification (HO) following hip arthroscopy is a common finding. Naproxen and celecoxib have both been found to decrease the incidence of HO. Whether this makes a clinical difference to outcomes is unclear at this time. A critical weighing of risks and benefits with regard to HO prophylaxis is warranted. Although the authors will personally continue to use nonsteroidal anti-inflammatory drugs for HO prophylaxis, it is up to the discerning reader to draw her/his own conclusion.
摘要
髋关节镜检查后异位骨化（HO）是一种常见的发现。已发现萘普生和塞来昔布均可降低 HO 的发生率。但目前尚不清楚这是否对结果有临床意义。对于 HO 的预防，权衡利弊是必要的。尽管作者个人将继续使用非甾体抗炎药预防 HO，但读者应自行得出结论。
相似文献
1
Editorial Commentary: The Curious Incident of the Bone in the Soft Tissue: Is Heterotopic Ossification After Hip Arthroscopy an Interesting Finding or Is It a Complication?编辑评论：软组织内骨的奇异事件：髋关节镜检查后异位骨化是有趣的发现还是并发症？
Arthroscopy. 2020 Feb;36(2):462-463. doi: 10.1016/j.arthro.2019.10.007.
2
Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.选择性环氧化酶-2抑制剂显著降低髋关节镜手术后异位骨化的发生率。
Am J Sports Med. 2016 Mar;44(3):677-81. doi: 10.1177/0363546515618623. Epub 2015 Dec 22.
3
Editorial Commentary: The Efficacy of Nonsteroidal Anti-inflammatory Drugs for Prophylaxis of Heterotopic Ossification in Hip Arthroscopy--Do We Treat Patients or X-rays?编辑评论：非甾体类抗炎药在髋关节镜检查中预防异位骨化的疗效——我们是治疗患者还是X光片？
Arthroscopy. 2016 Mar;32(3):526-7. doi: 10.1016/j.arthro.2015.12.035.
4
The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.非甾体抗炎药预防及手术变量对髋关节镜检查后异位骨化的影响
Am J Sports Med. 2014 Jun;42(6):1359-64. doi: 10.1177/0363546514526361. Epub 2014 Mar 24.
5
Incidence of heterotopic ossification following hip arthroscopy is low: considerations for routine prophylaxis.髋关节镜检查后异位骨化的发生率较低：常规预防的考虑因素。
Int Orthop. 2022 Jul;46(7):1489-1500. doi: 10.1007/s00264-022-05402-4. Epub 2022 Apr 28.
6
Chemoprophylaxis for heterotopic ossification following hip arthroscopy: A systematic review.髋关节镜术后异位骨化的化学预防：系统评价。
J ISAKOS. 2023 Dec;8(6):484-489. doi: 10.1016/j.jisako.2023.08.005. Epub 2023 Aug 23.
7
Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.后路全髋关节置换术中多模式镇痛方案后异位骨化的发生率
Orthopedics. 2018 Jan 1;41(1):e92-e97. doi: 10.3928/01477447-20171102-01. Epub 2017 Nov 9.
8
The Reduction of Heterotopic Ossification Incidence After Hip Arthroscopy in Patients Treated With Selective Cyclooxygenase 2 Inhibitor (Celecoxib).选择性环氧化酶 2 抑制剂（塞来昔布）治疗髋关节镜术后异位骨化发生率降低。
Arthroscopy. 2020 Feb;36(2):453-461. doi: 10.1016/j.arthro.2019.08.034. Epub 2019 Nov 14.
9
The incidence of heterotopic ossification after hip arthroscopy.髋关节镜检查后异位骨化的发生率。
Am J Sports Med. 2012 Apr;40(4):854-63. doi: 10.1177/0363546511434285. Epub 2012 Jan 20.
10
Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.髋部和髋臼手术后异位骨化的药物治疗
Expert Opin Pharmacother. 2008 Apr;9(5):767-86. doi: 10.1517/14656566.9.5.767.
Zotero 插件